| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NeuroBo Pharmaceuticals, Inc. | CEO & President, Director | Common Stock | 61K | $89.1K | $1.46 | Mar 1, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MTVA | MetaVia Inc. | Mar 1, 2025 | 1 | -$4.08K | 4 | Mar 4, 2025 | CEO & President, Director |
| MTVA | MetaVia Inc. | Nov 30, 2024 | 1 | -$7.31K | 4 | Dec 2, 2024 | CEO & President, Director |
| NRBO | NeuroBo Pharmaceuticals, Inc. | Aug 11, 2024 | 1 | -$41.3K | 4 | Aug 13, 2024 | CEO & President, Director |
| NRBO | NeuroBo Pharmaceuticals, Inc. | Aug 11, 2023 | 1 | $0 | 4 | Aug 14, 2023 | CEO & President, Director |
| NRBO | NeuroBo Pharmaceuticals, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| NRBO | NeuroBo Pharmaceuticals, Inc. | Jul 9, 2021 | 0 | $0 | 3 | Jul 19, 2021 | Director |